4th Mar 2014 11:16 am |
RNS |
Transfer of production |
26th Feb 2014 7:00 am |
RNS |
Final Results |
18th Feb 2014 7:00 am |
RNS |
Quo-Lab registration in Mexico |
17th Feb 2014 7:00 am |
RNS |
Notice of Results |
28th Jan 2014 12:21 pm |
RNS |
Additional Listing |
27th Jan 2014 7:00 am |
RNS |
Year end trading update |
24th Jan 2014 7:00 am |
RNS |
Holding(s) in Company |
20th Jan 2014 7:00 am |
RNS |
PointMan enriches low-level mutations from blood |
19th Nov 2013 7:00 am |
RNS |
Acute Kidney Injury marker development |
4th Nov 2013 7:00 am |
RNS |
New PointManT DNA enrichment products launched |
30th Oct 2013 3:10 pm |
RNS |
Holding(s) in Company |
8th Oct 2013 8:25 am |
RNS |
Holding(s) in Company |
3rd Oct 2013 9:03 am |
RNS |
Change of Registered Office |
25th Sep 2013 11:34 am |
RNS |
Holding(s) in Company |
19th Sep 2013 7:28 am |
RNS |
Investor Results Briefing |
16th Sep 2013 7:00 am |
RNS |
Interim Results |
14th Aug 2013 7:00 am |
RNS |
Investor Teach-In |
1st Aug 2013 7:00 am |
RNS |
Trading update |
25th Jul 2013 7:00 am |
RNS |
Investor Teach-In |
23rd Jul 2013 7:00 am |
RNS |
Senior management update |
4th Jul 2013 12:09 pm |
RNS |
Holding(s) in Company |
26th Jun 2013 5:43 pm |
RNS |
Analyst & Investor Teach-In |
18th Jun 2013 10:17 am |
RNS |
Director Share Transfer |
11th Jun 2013 3:52 pm |
RNS |
Amendment to Long-Term Incentive Plan |
15th May 2013 4:34 pm |
RNS |
Result of AGM |
15th May 2013 7:00 am |
RNS |
AGM Statement |
13th May 2013 7:00 am |
RNS |
First PointMan DNA enrichment products launched |
15th Apr 2013 1:34 pm |
RNS |
Publication of Annual Report & Notice of AGM |
18th Mar 2013 7:00 am |
RNS |
Final Results |
4th Mar 2013 7:00 am |
RNS |
Establishment of EKF Molecular & Acquisition |
18th Jan 2013 7:00 am |
RNS |
Pre-close Trading Update |
21st Dec 2012 3:53 pm |
RNS |
Directors' Exercise of Options |
17th Dec 2012 7:00 am |
RNS |
Holding(s) in Company |
27th Nov 2012 4:32 pm |
RNS |
Holding(s) in Company |
9th Nov 2012 7:00 am |
RNS |
Issue of Equity |
24th Sep 2012 7:00 am |
RNS |
Half Yearly Report |
5th Sep 2012 7:00 am |
RNS |
Trading Update |
14th Aug 2012 7:00 am |
RNS |
NICE guidance on type 2 diabetes |
10th Aug 2012 7:00 am |
RNS |
HemoCue settlement agreement |
17th Jul 2012 7:00 am |
RNS |
Licensing agreement for kidney markers |